Skip to main content
MS-DRG 754 · MDC 13 · Medical

MS-DRG 754: Malignancy, Female Reproductive System with MCC

Reviewed by QuickIntell RCM Editorial Team · Last reviewed

Data effective
Data currency: IPPS Table 5 FY2027 final rule (effective October 1, 2026); Definitions Manual v44 (effective October 1, 2026). Next CMS release: April 1, 2027 (v44.1 mid-year update), then the FY2028 final rule in August 2027.

Key facts for DRG 754

FY2027 relative weight
1.8080
Higher than 57% of all MS-DRGs
Change vs FY2026
-1.9%
FY2026 weight 1.8420
Geometric mean LOS
5.0 days
Arithmetic mean 6.9 days
MDC
13
Assignment of Diagnosis Codes
Severity level
with MCC (major complication or comorbidity)
Transfer policy
Not a transfer DRG

TL;DR

MS-DRG 754 is a medical group in MDC 13 (Assignment of Diagnosis Codes) at the highest-severity level of its family. CMS assigns it a FY2027 relative weight of 1.8080 with a geometric mean length of stay of 5.0 days and an arithmetic mean of 6.9. Its weight moved down 1.9% from FY2026 (1.8420). That weight is higher than 57% of all medical and surgical MS-DRGs. Its CC/MCC family (DRG 755, DRG 756) spans weights 0.8650 to 1.8080. The v44 Definitions Manual assigns it through 58 principal diagnosis codes.

What changed from FY2026 to FY2027

CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 754 the FY2027 relative weight is 1.8080 against 1.8420 in FY2026, a fall of 1.85%.

FY2026 versus FY2027 payment factors for MS-DRG 754
MetricFY2026FY2027Change
Relative weight1.84201.8080-0.0340
Geometric mean LOS (days)5.15.0-0.1
Arithmetic mean LOS (days)7.16.9-0.2
Weights shown are the FY2027 final values after the 10% cap on year-over-year reductions where applicable.

CC and MCC family

DRG 754 shares its base definition with 2 other MS-DRGs split by severity. The family's weights span 0.8650 to 1.8080, a 2.09× spread, which is the payment effect of documenting qualifying complications and comorbidities.

MS-DRGs in the same base group as DRG 754
DRGTitleFY2027 weightGMLOS
754Malignancy, Female Reproductive System with MCC1.80805.0
755Malignancy, Female Reproductive System with CC1.14903.2
756Malignancy, Female Reproductive System without CC/MCC0.86502.0

Grouper logic (v44 Definitions Manual)

Principal Diagnosis: 58 ICD-10 codes drive assignment to this group; the first 12 are shown.

Principal Diagnosis codes assigned to DRG 754 (sample)
ICD-10 codeDescription
C510Malignant neoplasm of labium majus
C511Malignant neoplasm of labium minus
C512Malignant neoplasm of clitoris
C518Malignant neoplasm of overlapping sites of vulva
C519Malignant neoplasm of vulva, unspecified
C52Malignant neoplasm of vagina
C530Malignant neoplasm of endocervix
C531Malignant neoplasm of exocervix
C538Malignant neoplasm of overlapping sites of cervix uteri
C539Malignant neoplasm of cervix uteri, unspecified
C540Malignant neoplasm of isthmus uteri
C541Malignant neoplasm of endometrium

Documentation and denial exposure

As a medical DRG, assignment depends on the principal diagnosis sequenced from the attending's documentation; a secondary condition sequenced first, or a symptom code in place of the confirmed diagnosis, changes the MDC or the DRG. Because this family splits by severity, auditors target CC and MCC capture: each secondary diagnosis must be documented as present, monitored, evaluated or treated during the stay to survive a DRG-validation review. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).

How QuickIntell uses DRG 754 data

QuickCode groups inpatient encounters against the current v44 logic, flags CC and MCC candidates that lack supporting documentation, and shows the weight difference across the family before the claim drops. QuickScribe captures the attending's language that supports severity, and QuickRCM works DRG-validation denials with the grouper evidence attached.

Frequently asked questions — DRG 754

What is MS-DRG 754?

MS-DRG 754 is "Malignancy, Female Reproductive System with MCC", a medical Medicare Severity Diagnosis-Related Group in MDC 13, Assignment of Diagnosis Codes. Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.

What is the FY2027 relative weight for DRG 754?

The FY2027 relative weight is 1.8080 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 1.8420, a change of -1.9%.

What is the average length of stay for DRG 754?

CMS reports a geometric mean length of stay of 5.0 days and an arithmetic mean of 6.9 days for FY2027. The geometric mean is used for transfer-payment calculations.

Which DRGs are in the same CC/MCC family as 754?

DRG 755 (Malignancy, Female Reproductive System with CC, weight 1.1490); DRG 756 (Malignancy, Female Reproductive System without CC/MCC, weight 0.8650). The family's weights range from 0.8650 to 1.8080, so documented complications and comorbidities change payment materially.

What documentation supports the severity level of DRG 754?

DRG 754 requires at least one secondary diagnosis on the CMS Major Complication or Comorbidity list, documented as present and clinically addressed during the stay (monitored, evaluated, treated or extending the stay). Conditions such as acute respiratory failure, severe sepsis or acute kidney injury with specified cause qualify only when the attending's note states the diagnosis itself, not just the lab values. Recovery auditors downgrade this group to the CC or base level when the MCC rests on an unconfirmed query or a resolved historical condition, so the query response and the discharge summary must agree.

Which codes group to DRG 754?

The v44 Definitions Manual lists 58 principal diagnosis codes for this group. Examples from the principal diagnosis list: C510 (Malignant neoplasm of labium majus); C511 (Malignant neoplasm of labium minus); C512 (Malignant neoplasm of clitoris); C518 (Malignant neoplasm of overlapping sites of vulva).

Is DRG 754 a post-acute transfer DRG?

No. DRG 754 is not on the FY2027 post-acute care transfer list, so the transfer per-diem policy does not apply to it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-01. Verify against the primary file before billing or contracting decisions.

Disclaimer

This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.